Category: Top Story
-
E-subsidy 2.0 and now the boom! Taking off with BYD, NEO Battery Materials, and VW
Now it is official! The German federal government is relaunching its e-subsidy program. Low- and middle-income earners can apply for environmental incentives of up to EUR 6,000 for the purchase of an electric or hybrid vehicle. Annual household income must not exceed EUR 80,000 for households without children, and EUR 90,000 for those with children.…
-
U.S. Stocks Finish Volatile Session Sharply Higher
After showing a strong move to the upside early in the session, stocks saw significant volatility over the course of the trading day on Wednesday. The major averages largely gave back their early gains in late morning trading before experiencing an afternoon resurgence and ending the day sharply higher. The major averages all posted strong…
-
U.S. equities set for potential further losses at the open: Dow Jones, S&P, Nasdaq, Wall Street Futures
U.S. stock index futures are signaling a slightly weaker start to Wednesday’s session, pointing to the possibility of additional declines after the sharp sell-off seen a day earlier. Investor sentiment remains fragile amid fears of an escalating trade dispute between the United States and Europe, sparked by President Donald Trump’s push to secure control of…
-
Netflix drops premarket after issuing cautious outlook amid Warner Bros. bid
Shares of Netflix (NASDAQ:NFLX) slid more than 5% in U.S. premarket trading on Wednesday after the streaming group released softer-than-expected forward guidance while pursuing a large acquisition of Warner Bros. Discovery (NASDAQ:WBD). For the quarter ended December 31, Netflix reported earnings of $0.56 per diluted share on revenue of $12.05 billion, narrowly topping analysts’ forecasts…
-
Kraft Heinz slips premarket after filing signals possible Berkshire exit
Shares of Kraft Heinz (NASDAQ:KHC) fell about 3.6% in premarket trading on Wednesday after a regulatory filing indicated that Berkshire Hathaway (NYSE:BRK.B) may look to sell its 27.5% stake in the food group. The disclosure showed that the conglomerate led by Warren Buffett is evaluating a potential divestment of its sizeable holding in Kraft Heinz,…
-
Musk warns Tesla Cybercab and Optimus rollout will start ‘agonizingly slow’
Tesla Inc (NASDAQ:TSLA) chief executive Elon Musk said on Tuesday that the initial manufacturing phase for the company’s upcoming Cybercab robotaxi and Optimus humanoid robot will progress at a very slow pace before accelerating significantly over time. Replying to a post on social media discussing Cybercab production, Musk cautioned that “for Cybercab and Optimus, almost…
-
U.S. futures edge higher as markets await Trump’s Davos speech; Netflix outlook, Berkshire filing in focus: Dow Jones, S&P, Nasdaq, Wall Street
Futures tied to the main U.S. equity benchmarks ticked up on Wednesday as unsettled markets looked ahead to President Donald Trump’s address at the annual World Economic Forum in Switzerland. Investor attention remains fixed on Trump’s push for U.S. control of Greenland — and his warnings of additional tariffs on several European countries — themes…
-
A clean technology company on the verge of transformational growth
The US green energy transition, while making clear and substantial strides, will rely on fossil fuels for decades to come as infrastructure slowly shifts towards sustainability. Coal is a prime example, with coal-fired plants accounting for 16 per cent of domestic power in 2023, a figure expected to decrease but remain significant into 2050 and beyond, highlighting how utilities across…
-
Renewed Trade War Concerns Spark Sell-Off On Wall Street
After ending last Friday’s choppy trading session modestly lower, stocks showed a more substantial move to the downside during trading on Tuesday. The major averages all moved sharply lower, adding to the losses posted last week. The major averages saw further downside late in the session, closing near their worst levels of the day. The…
-
BioVaxys posts encouraging ovarian cancer data from MVP-S combo trial
BioVaxys Technology Corp. (CSE:BIOV) (USOTC:BVAXF) said it has reported positive early results from its Phase 1B/2 PESCO clinical study evaluating its cancer vaccine MVP-S in combination with pembrolizumab (Keytruda™) and low-dose cyclophosphamide in patients with recurrent epithelial ovarian cancer. The open-label, investigator-initiated trial assessed safety, dosing and early signs of efficacy in patients with relapsed…